We make forward-looking statements herein and will make forward-looking
statements in future filings with the SEC, press releases or other written or
oral communications within the meaning of Section 27A of the Securities Act of
1933, as amended (the "Securities Act"), and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"). For these statements, we
claim the protections of the safe harbor for forward-looking statements
contained in such Sections. Forward-looking statements are subject to
substantial risks and uncertainties, many of which are difficult to predict and
are generally beyond our control. These forward-looking statements include
information about possible or assumed future results of our business, financial
condition, liquidity, results of operations, plans and objectives. When we use
the words "believe," "expect," "anticipate," "estimate," "plan," "continue,"
"intend," "should," "may" or similar expressions, it intends to identify
forward-looking statements. Statements regarding the following subjects, among
others, may be forward-looking: the macro- and micro-economic impact of the
COVID-19 pandemic; the severity and duration of the COVID-19 pandemic; actions
taken by governmental authorities to contain the COVID-19 pandemic or treat its
impact; the impact of the COVID-19 pandemic on our financial condition, results
of operations, liquidity and capital resources; market trends in our industry,
interest rates, real estate values, the debt securities markets or the general
economy; the demand for commercial real estate loans; our business and
investment strategy; our operating results; actions and initiatives of the U.S.
government and governments outside of the United States, changes to government
policies and the execution and impact of these actions, initiatives and
policies; the state of the economy generally or in specific geographic regions;
economic trends and economic recoveries; our ability to obtain and maintain
financing arrangements, including secured debt arrangements and securitizations;
the timing and amount of expected future fundings of unfunded commitments; the
availability of debt financing from traditional lenders; the volume of
short-term loan extensions; the demand for new capital to replace maturing
loans; expected leverage; general volatility of the securities markets in which
we participate; changes in the value of our assets; the scope of our target
assets; interest rate mismatches between our target assets and any borrowings
used to fund such assets; changes in interest rates and the market value of our
target assets; changes in prepayment rates on our target assets; effects of
hedging instruments on our target assets; rates of default or decreased recovery
rates on our target assets; the degree to which hedging strategies may or may
not protect us from interest rate volatility; impact of and changes in
governmental regulations, tax law and rates, accounting, legal or regulatory
issues or guidance and similar matters; our continued maintenance of our
qualification as a REIT for U.S. federal income tax purposes; our continued
exclusion from registration under the Investment Company Act of 1940, as
amended; the availability of opportunities to acquire commercial
mortgage-related, real estate-related and other securities; the availability of
qualified personnel; estimates relating to our ability to make distributions to
our stockholders in the future; our present and potential future competition;
and unexpected costs or unexpected liabilities, including those related to
litigation.
The forward-looking statements are based on our beliefs, assumptions and
expectations of our future performance, taking into account all information
currently available to us. Forward-looking statements are not predictions of
future events. These beliefs, assumptions and expectations can change as a
result of many possible events or factors, not all of which are known to us. See
"Item 1A. Risk Factors" of this Quarterly Report on Form 10-Q and our Annual
Report. These and other risks, uncertainties and factors, including those
described in the annual, quarterly and current reports that we file with the
SEC, could cause our actual results to differ materially from those included in
any forward-looking statements we make. All forward-looking statements speak
only as of the date they are made. New risks and uncertainties arise over time
and it is not possible to predict those events or how they may affect us. Except
as required by law, we are not obligated to, and do not intend to, update or
revise any forward-looking statements, whether as a result of new information,
future events or otherwise.
Overview
We are a Maryland corporation and have elected to be taxed as a REIT for U.S.
federal income tax purposes. We primarily originate, acquire, invest in and
manage performing commercial first mortgage loans, subordinate financings, and
other commercial real estate-related debt investments. These asset classes are
referred to as our target assets.
We are externally managed and advised by the Manager, an indirect subsidiary of
Apollo, a leading global alternative investment manager with a contrarian and
value-oriented investment approach in private equity, credit and real estate
with assets under management of approximately $315.5 billion as of March 31,
2020.
The Manager is led by an experienced team of senior real estate professionals
who have significant expertise in underwriting and structuring commercial real
estate financing transactions. We benefit from Apollo's global infrastructure
and operating platform, through which we are able to source, evaluate and manage
potential investments in our target

                                       29


--------------------------------------------------------------------------------

assets.

Current Market Conditions



During the first quarter of 2020, there was a global outbreak of COVID-19, which
was declared by the World Health Organization as a pandemic. In response to
COVID-19, the United States and numerous other countries declared national
emergencies, which has led to large scale quarantines as well as restrictions to
business deemed non-essential. These responses to COVID-19 have disrupted
economic activities and could have a significant continued adverse effect on
economic and market conditions, and could result in a recession. As we are still
in the midst of the COVID-19 pandemic we are not in a position to estimate the
ultimate impact this will have on our business and the economy as a whole. The
effects of COVID-19 have adversely impacted the value of our assets, business,
financial condition, results of operations and cash flows, and our ability to
operate successfully. Some of the factors that impacted us to date and may
continue to affect us are outlined in "Item 1A. Risk Factors" of this Quarterly
Report on Form 10-Q. Please see "Liquidity and Capital Resources" below for
additional discussion surrounding the ongoing impact we expect COVID-19 will
have on our liquidity and capital resources.
Critical Accounting Policies

A summary of our critical accounting policies is set forth in our Annual Report
under "Item 7. Management's Discussion and Analysis of Financial Condition and
Results of Operations - Critical Accounting Policies and Use of Estimates."
There have been no material changes to our critical accounting policies
described in our Annual Report other than the adoption of the CECL Standard, as
described in "Note 2 - Summary of Significant Accounting Policies."
Results of Operations
All non-USD denominated assets and liabilities are translated to USD at the
exchange rate prevailing at the reporting date and income, expenses, gains, and
losses are translated at the prevailing exchange rate on the dates that they
were recorded.
Loan Portfolio Overview
The following table sets forth certain information regarding our commercial real
estate debt portfolio as of March 31, 2020 ($ in thousands):
                                                                  Weighted
                            Amortized       Weighted-Average       Average       Secured Debt                           Equity at
      Description             Cost             Coupon (1)          All-in      Arrangements (3)     Cost of Funds        cost(4)
                                                                    Yield
                                                                   (1)(2)
Commercial mortgage
loans, net                $ 5,413,627               4.8 %              5.3 %   $     3,556,842            2.7 %      $   1,856,785
Subordinate loans and
other lending assets,       1,016,991              12.4 %             13.9 %                 -              -            1,016,991
net
Total/Weighted-Average    $ 6,430,618               6.0 %              6.7 %   $     3,556,842            2.7 %      $   2,873,776


-------

(1) Weighted-Average Coupon and Weighted-Average All-in Yield are based on the

applicable benchmark rates as of March 31, 2020 on the floating rate loans.

(2) Weighted-Average All-in Yield includes the amortization of deferred

origination fees, loan origination costs and accrual of both extension and

exit fees. Weighted-Average All-in Yield excludes the benefit of forward

points on currency hedges relating to loans denominated in currencies other

than USD.

(3) Gross of deferred financing costs of $16.9 million.

(4) Represents loan portfolio at amortized cost less secured debt outstanding.




The following table provides details of our commercial mortgage loan portfolio
and subordinate and other lending assets portfolio, on a loan-by-loan basis, as
of March 31, 2020 ($ in millions):
Commercial Mortgage Loan Portfolio
                                                                     Unfunded  Construction Fully-extended
#     Property Type     Risk Rating Origination Date Amortized Cost Commitment     Loan        Maturity      Location
1 Urban Retail               3          08/2019           $316          $-                     09/2024     Manhattan, NY
2 Urban Retail               3          12/2019           308           -                      12/2023     London, UK



                                       30


--------------------------------------------------------------------------------


3  Hotel                  3   10/2019   240      52              08/2024  Various
4  Healthcare             3   10/2019   212      28              10/2024  Various
5  Office                 3   02/2020   207      -               02/2025  London, UK
6  Industrial             3   01/2019   196      7               02/2024  Brooklyn, NY
                                                                          Berlin,
7  Office                 3   06/2019   192      27              11/2026  Germany
                                                                          Manhattan,
8  Office                 3   10/2018   191      8               10/2021  NY
9  Office                 3   09/2019   172      -               09/2023  London, UK
                                                                          Long Island
10 Office                 3   01/2020   166     121              02/2025  City, NY
11 Office                 3   11/2017   158      -               01/2023  Chicago, IL
12 Hotel                  3   04/2018   152      2               04/2023  Honolulu, HI
13 Hotel                  3   05/2018   140      -               06/2023  Miami, FL
                                                                          Manhattan,
14 Hotel (1)              5   09/2015   144      -               06/2023  NY
                                                                          Puglia,
15 Hotel                  3   08/2019   131      -               08/2024  Italy
16 Office                 3   01/2018   130      60              01/2022  Renton, WA
   Urban Predevelopment
17 (1)                    5   03/2017   126      9               12/2020  Brooklyn, NY
   Urban Predevelopment
18 (1)                    5   01/2016   118      -               09/2021  Miami, FL
   Residential-for-sale:
19 inventory              3   03/2018   121      -               03/2021  London, UK
                                                                          Manhattan,
20 Office                 3   10/2018   121      65       Y      10/2023  NY
   Residential-for-sale:
21 construction           3   12/2019   114      35       Y      01/2023  Boston, MA
22 Hotel                  3   03/2017   105      -               03/2022  Atlanta, GA
                                                                          Cincinnati,
23 Retail center          5   11/2014   104      -               09/2020  OH
24 Hotel                  3   11/2018   99       -               12/2023  Vail, CO
                                                                          Manhattan,
25 Hotel                  3   12/2017   89       -               12/2022  NY
26 Office                 3   03/2018   89       3               04/2023  Chicago, IL
   Residential-for-sale:                                                  Manhattan,
27 inventory              3   12/2019   82       -               07/2021  NY
                                                                          Culver City,
28 Office                 3   04/2019   76       83       Y      09/2025  CA
29 Office                 3   12/2017   74       45              07/2022  London, UK
30 Mixed Use              3   12/2019   72       1               12/2024  London, UK
   Residential-for-sale:                                                  Manhattan,
31 construction           3   12/2018   70      107       Y      12/2023  NY
32 Multifamily            3   04/2014   69       -               07/2023  Various
                                                                          Manhattan,
33 Hotel                  3   08/2019   67       -               09/2022  NY
                                                                          Scottsdale,
34 Hotel                  3   04/2018   63       -               05/2023  AZ
                                                                          Los Angeles,
35 Urban Predevelopment   3   12/2016   63       -               06/2020  CA
36 Hotel                  3   09/2019   60       -               10/2024  Miami, FL
   Residential-for-sale:                                                  Manhattan,
37 construction           3   01/2018   60       20       Y      01/2023  NY
38 Hotel                  3   12/2019   60       -               01/2025  Tucson, AZ
39 Multifamily            3   11/2014   54       -               11/2021  Various
40 Hotel                  3   05/2019   52       -               06/2024  Chicago, IL
                                                                          Cleveland,
41 Multifamily            3   02/2020   50       1               03/2024  Ohio
42 Multifamily            3   06/2018   47       -               06/2020  London, UK
43 Office                 3   08/2018   42      148       Y      12/2022  London, UK
                                                                          St. Thomas,
44 Hotel                  3   12/2015   42       -               08/2024  USVI
   Residential-for-sale:                                                  Hallandale
45 construction           3   12/2018   40       62       Y      01/2024  Beach, FL
                                                                          Birmingham,
46 Office                 3   04/2019   35       37       Y      08/2022  UK
                                                                          Pittsburgh,
47 Hotel (1)              5   02/2018   31       -               03/2023  PA
48 Office                 3   12/2019   29       6               12/2022  Edinburgh,
                                                                          Scotland
                                                                          San
   Residential-for-sale:                                                  Francisco,
49 construction           3   03/2018   26       88       Y      03/2023  CA
   Residential-for-sale:                                                  Manhattan,
50 inventory              2   05/2018   24       -               04/2021  NY
   Residential-for-sale:                                                  Manhattan,
51 inventory              3   06/2018   18       -               06/2020  NY
   Residential-for-sale:
52 inventory (1)          5   02/2014    3       -               04/2021  Bethesda, MD
53 Mixed Use              3   12/2019   (8)     777       Y      06/2025  London, UK
   General CECL
   Allowance             N/A           (28)
   Sub total /
   Weighted-Average
   Commercial Mortgage
   Loans                 3.2          $5,414   $1,792           3.3 Years



                                       31


--------------------------------------------------------------------------------

Subordinate Loan and Other Lending Asset Portfolio

Unfunded Construction Fully-extended # Property Type Risk Rating Origination Date Amortized Cost Commitment Loan(5) Maturity Location

Residential-for-sale:


1  construction (2)              3          06/2015           $216          -           Y          02/2021     Manhattan, NY

Residential-for-sale:


2  construction                  3          12/2017           100           15          Y          06/2022     Manhattan, NY
3  Office                        3          01/2019           100           -                      12/2025     Manhattan, NY
4  Healthcare                    3          01/2019            76           -                      01/2024     Various
5  Multifamily                   3          10/2015            69           -                      11/2020     Manhattan, NY

Residential-for-sale:


6  construction                  3          12/2017            68           -           Y          04/2023     Los Angeles, CA

Residential-for-sale:


7  construction (2)              3          11/2017            68           -           Y          02/2021     Manhattan, NY
8  Healthcare (3)                3          07/2019            51           -                      06/2024     Various
9  Mixed Use                     3          01/2017            42           -                      02/2027     Cleveland, OH

Residential-for-sale:


10 inventory                     2          10/2016            36           -                      10/2020     Manhattan, NY
11 Mixed Use                     3          02/2019            36           -           Y          12/2022     London, UK
12 Industrial                    2          05/2013            32           -                      05/2023     Various
13 Mixed Use                     3          12/2018            26           25          Y          12/2023     Brooklyn, NY
14 Hotel                         2          06/2015            24           -                      07/2025     Phoenix, AZ
15 Hotel                         3          06/2018            20           -                      06/2023     Las Vegas, NV
16 Multifamily                   3          05/2018            19           -                      05/2028     Cleveland, OH
17 Healthcare (3)                3          02/2019            17           -                      01/2034     Various
18 Office                        2          07/2013            14           -                      07/2022     Manhattan, NY
19 Hotel (3)                     5          06/2015            10           -                      12/2022     Washington, DC
20 Hotel                         3          05/2017            8            -                      06/2027     Anaheim, CA
21 Office                        3          08/2017            8            -                      09/2024     Troy, MI
22 Mixed Use                     3          07/2012            7            -                      08/2022     Chapel Hill, NC

   General CECL Allowance                                     (30)
   Sub total /
   Weighted-Average
   Subordinate Loans and
   Other Lending Assets         2.9                          $1,017        $40                    3.0 Years

Total / Weighted-Average


   Loan Portfolio               3.1                          $6,431       $1,832                  3.3 Years


-------
(1) Amortized cost for these loans is net of the recorded provisions for loan
losses.
(2) Both loans are secured by the same property.
(3) Single Asset, Single Borrower CMBS.

Our average asset and debt balances for the three months ended March 31, 2020
were ($ in thousands):
                                            Average month-end balances for the three months
                                                         ended March 31, 2020
Description                                         Assets                 Related debt
Commercial mortgage loans, net             $            5,579,719     $     

3,231,713


Subordinate loans and other lending
assets, net                                             1,063,453                        -


Investment Activity
During the three months ended March 31, 2020, we committed $562.0 million of
capital to loans ($439.9 million of which was funded during the three months
ended March 31, 2020). In addition, during the three months ended March 31,
2020, we funded $118.5 million for loans closed prior to 2020, and received
$210.7 million in repayments and sales.

Net Income (Loss) Available to Common Stockholders
For the three months ended March 31, 2020 and 2019, respectively, our net income
(loss) available to common stockholders was $(131.2) million, or $(0.86) per
diluted share of common stock, and $60.9 million, or $0.43 per diluted

                                       32


--------------------------------------------------------------------------------

share of common stock, respectively.
Operating Results
The following table sets forth information regarding our consolidated results of
operations and certain key operating metrics ($ in thousands):
                                                        Three months ended March 31,        2020 vs 2019
                                                           2020                2019
Net interest income:
Interest income from commercial mortgage loans      $        81,855       $     78,286     $       3,569
Interest income from subordinate loans and other             34,018             40,839            (6,821 )
lending assets
Interest expense                                            (41,205 )          (36,295 )          (4,910 )
Net interest income                                          74,668             82,830            (8,162 )
Operating expenses:
General and administrative expenses                          (6,531 )           (6,151 )            (380 )
Management fees to related party                            (10,268 )           (9,613 )            (655 )
Total operating expenses                                    (16,799 )          (15,764 )          (1,035 )
Other income                                                    760                518               242

Provision for loan losses - Specific CECL Allowance (150,000 )

          -          (150,000 )
Provision for loan losses - General CECL Allowance          (33,465 )                -           (33,465 )
Foreign currency gain (loss)                                (37,949 )            6,894           (44,843 )
Gain (loss) on foreign currency forwards                     70,491             (6,720 )          77,211
Unrealized loss on interest rate swap                       (35,548 )                -           (35,548 )
Net income (loss)                                   $      (127,842 )     $ 

67,758 $ (195,600 )

Net Interest Income



Net interest income decreased by $8.2 million during the three months ended
March 31, 2020 as compared to the same period in 2019. The decrease was
primarily due to (i) a 1.09% decrease in average one-month LIBOR for the three
months ended March 31, 2020 compared to March 31, 2019 and (ii) an increase in
interest expense due to an increase in our net debt balance of $1.9 billion as
of March 31, 2020 compared to March 31, 2019. This decrease was offset by (i) a
$1.5 billion increase in loan principal balance as of March 31, 2020 compared to
March 31, 2019 and (ii) in the money LIBOR floors on several of our loans.
We recognized $0.2 million and $3.7 million in pre-payment penalties and
accelerated fees for the three months ended March 31, 2020 and 2019,
respectively.

We recognized PIK interest of $12.4 million and $14.5 million for the three
months ended March 31, 2020 and 2019, respectively.
Operating Expenses
General and administrative expenses
General and administrative expenses increased by $0.4 million for the three
months ended March 31, 2020 compared to the same period in 2019. The increase
was primarily driven by a $0.4 million increase in non-cash restricted stock and
RSU amortization related to shares of common stock awarded under the LTIPs.
Management fees to related party
Management fee expense increased by $0.7 million during the three months ended
March 31, 2020 as compared to the same periods in 2019. The increase is
primarily attributable to an increase in our stockholders' equity (as defined in
the Management Agreement) as a result of us completing the follow-on public
offering of 17,250,000 shares during the second quarter of 2019 (as described in
"Note 14 - Stockholders' Equity").

                                       33


--------------------------------------------------------------------------------

Management fees and the relationship between us and the Manager under the
Management Agreement are discussed further in the accompanying condensed
consolidated financial statements, in "Note 12 - Related Party Transactions."
Provision for loan losses - General CECL Allowance
The General CECL Allowance increased by $33.5 million during the three months
ended March 31, 2020. The increase is predominantly related to a change in our
view of estimated macro-economic conditions, including unemployment rate and
commercial real estate price index, in the backdrop of the COVID-19 global
pandemic. Other factors that contributed to the increase include an increase in
our view of remaining expected term of our loan portfolio and growth in the
portfolio from new investments during the quarter. Refer to "Note 2 - Summary of
Significant Accounting Policies" and "Note 4 - Commercial Mortgage, Subordinate
Loans and Other Lending Assets, Net" for additional information related to our
General CECL Allowance.
Provision for loan losses - Specific CECL Allowance
During the three months ended March 31, 2020, we recorded impairments on five
new loans and increased the Specific CECL Allowance on two loans that previously
had loan loss provisions, primarily due to the impact from COVID-19. Refer to
"Note 4 - Commercial Mortgage, Subordinate Loans and Other Lending Assets, Net"
for additional information related to our Specific CECL Allowance.
Foreign currency gain and (loss) on derivative instruments
We use forward currency contracts to economically hedge interest and principal
payments due under our loans denominated in currencies other than USD. When
foreign currency gain and (loss) on derivative instruments are evaluated on a
combined basis, the net impact for the three months ended March 31, 2020 and
2019 was $32.5 million and $0.2 million, respectively.
Unrealized loss on interest rate swap
We use an interest rate swap to manage exposure to variable cash flows on
portions of our borrowings under our senior secured term loan. The interest rate
swap agreement allows us to receive a variable rate cash flow based on LIBOR and
pay a fixed rate cash flow, mitigating the impact of this exposure. For the
three months ended March 31, 2020, we had an unrealized loss on the interest
rate swap of $35.5 million. We did not have the interest rate swap at any point
during the three months ended March 31, 2019.
Dividends
We have declared the following dividends in 2020:


Dividend declared per share of: March 31, 2020
Common Stock                        $0.40
Series B Preferred Stock             0.50


Subsequent Events
Refer to "Note 18 - Subsequent Events" to the accompanying condensed
consolidated financial statements for disclosure regarding significant
transactions that occurred subsequent to March 31, 2020.
Liquidity and Capital Resources
Liquidity is a measure of our ability to meet potential cash requirements,
including ongoing commitments to repay borrowings, fund and maintain our assets
and operations, make distributions to our stockholders and other general
business needs. As of March 31, 2020, we had $1.1 billion of corporate debt and
$3.6 billion of asset specific financings. We have no corporate debt maturities
until August 2022. As of March 31, 2020, we had $582 million of cash on hand and
$8 million of approved and undrawn capacity from our secured debt arrangements.
In addition, we have a significant amount of unencumbered loan assets. In light
of COVID-19 and its severe impact on the economy we have taken steps to increase
our cash balances in order to maintain an adequate level of liquidity to meet
future outflows. As the duration and severity of COVID-19 remain unknown, so
does the impact it will have on our borrowers, lenders, and the economy as a
whole. We will continue to closely monitor developments related to COVID-19 as
it relates to our liquidity position and

                                       34


--------------------------------------------------------------------------------

financial obligations. At this time we believe we have sufficient liquidity and
access to additional liquidity to meet financial obligations for at least the
next 12 months.
Debt-to-Equity Ratio
The following table presents our debt-to-equity ratio:
                         March 31, 2020   December 31, 2019
Debt to Equity Ratio (1)      1.6                1.4


-------


(1) Represents total debt less cash and loan proceeds held by servicer to total
stockholders' equity.
Our primary sources of liquidity are as follows:
Cash Generated from Operations
Cash from operations is generally comprised of interest income from our
investments, net of any associated financing expense, principal repayments from
our investments, net of associated financing repayments, proceeds from the sale
of investments, and changes in working capital balances. See "Results of
Operations - Loan Portfolio Overview" above for a summary of interest rates
related to our investment portfolio as of March 31, 2020.

Borrowings Under Various Financing Arrangements
JPMorgan Facility
In November 2019, through three indirect wholly-owned subsidiaries, we entered
into a Sixth Amended and Restated Master Repurchase Agreement with JPMorgan
Chase Bank, National Association. The JPMorgan Facility allows for $1.3 billion
of maximum borrowings (with amounts borrowed in British pounds and Euros
converted to U.S. dollars for purposes of calculating availability based on the
greater of the spot rate as of the initial financing under the corresponding
mortgage loan and the then-current spot rate) and matures in June 2022 and has
two one-year extensions available at our option, which are subject to the
approval of JPMorgan and certain other conditions. The JPMorgan Facility enables
us to elect to receive advances in U.S. dollars, British pounds, or Euros.
Margin calls may occur any time at specified aggregate margin deficit
thresholds.
As of March 31, 2020, we had $1.2 billion (including £75.6 million and €60.0
million assuming conversion into USD) of borrowings outstanding under the
JPMorgan Facility secured by certain of our commercial mortgage loans.
DB Facility
In March 2020, through an indirect wholly-owned subsidiary, we entered into a
Third Amended and Restated Master Repurchase Agreement with Deutsche Bank AG,
Cayman Islands Branch, London Branch, which provides for advances of up to $1.0
billion for the sale and repurchase of eligible first mortgage loans secured by
commercial or multifamily properties located in the United States, United
Kingdom and the European Union, and enables us to elect to receive advances in
USD, GBP, or EUR. The repurchase facility matures in March 2021, and has two
one-year extensions available at our option, subject to certain conditions.
Margin calls may occur any time at specified aggregate margin deficit
thresholds.
As of March 31, 2020, we had $507.0 million of borrowings outstanding under the
DB Facility secured by certain of our commercial mortgage loans.
Goldman Facility
In November 2017, through an indirect wholly-owned subsidiary, we entered into a
master repurchase and securities contract agreement with Goldman Sachs Bank USA,
which provides advances up to $500.0 million and matures in November 2020, and
has one one-year extension available at our option, subject to certain
conditions. Margin calls may occur any time at specified margin deficit
thresholds.
As of March 31, 2020, we had $359.5 million of borrowings outstanding under the
Goldman Facility secured by certain of our commercial mortgage loans.
CS Facility - USD

                                       35


--------------------------------------------------------------------------------

In July 2018, through an indirect wholly-owned subsidiary, we entered into a
Master Repurchase Agreement with Credit Suisse AG, acting through its Cayman
Islands Branch and Alpine Securitization Ltd, which provides for advances for
the sale and repurchase of eligible commercial mortgage loans secured by real
estate. The CS Facility - USD has an "evergreen" feature such that the facility
continues unless terminated at any time by Credit Suisse with six months'
notice. Margin calls may occur any time at specified aggregate margin deficit
thresholds.
As of March 31, 2020, we had $325.9 million of borrowings outstanding under the
CS Facility - USD secured by certain of our commercial mortgage loans.
CS Facility - GBP
In June 2018, through an indirect wholly-owned subsidiary, we entered into a
Global Master Repurchase Agreement with Credit Suisse Securities (Europe)
Limited, which provides for advances for the sale and repurchase of eligible
commercial mortgage loans secured by real estate. The CS Facility - GBP matures
in September 2020. Margin calls may occur any time at specified aggregate margin
deficit thresholds.
As of March 31, 2020, we had $84.7 million (£68.2 million assuming conversion
into USD) of borrowings outstanding under the CS Facility - GBP secured by one
commercial mortgage loan.
HSBC Facility - USD
In October 2019, through an indirect wholly-owned subsidiary, we entered into a
secured debt arrangement with HSBC Bank plc, which provides for a single asset
financing. The facility is scheduled to mature in January 2021. Margin calls may
occur any time at specified aggregate margin thresholds.
As of March 31, 2020, we had $50.6 million of borrowings under the HSBC Facility
- USD secured by one commercial mortgage loan.
HSBC Facility - GBP
In September 2018, through an indirect wholly-owned subsidiary, we entered into
a secured debt arrangement with HSBC Bank plc, which provides for a single asset
financing. The facility is scheduled to mature in June 2020. Margin calls may
occur any time at specified aggregate margin deficit thresholds.
As of March 31, 2020, we had $32.2 million (£26.0 million assuming conversion
into USD) of borrowings outstanding under the HSBC Facility - GBP secured by one
commercial mortgage loan.
HSBC Facility - EUR
In July 2019, through an indirect wholly-owned subsidiary, we entered into a
secured debt arrangement with HSBC Bank plc, which provides for a single asset
financing. The facility matures in July 2021. Margin calls may occur any time at
specified aggregate margin deficit thresholds.
As of March 31, 2020, we had $151.5 million (€137.4 million assuming conversion
into USD) of borrowings outstanding under the HSBC Facility - EUR secured by one
of our commercial mortgage loans.
Barclays Facility - USD
In March 2020, through an indirect wholly-owned subsidiary, we entered into a
secured debt arrangement pursuant to a Master Repurchase Agreement with Barclays
Bank plc. The Barclays Facility - USD allows for $200.0 million of maximum
borrowings and initially matures in March 2023 with extensions available at our
option, subject to certain conditions. Margin calls may occur any time at
specified aggregate margin deficit thresholds.
Barclays Facility - GBP/EUR
Beginning in October 2019, through an indirect wholly-owned subsidiary, we
entered into five secured debt arrangements pursuant to a Global Master
Repurchase Agreement with Barclays Bank plc. Margin calls may occur any time at
specified aggregate margin deficit thresholds.
The table below provides the currency, outstanding balance, stated maturity, and
extended maturity for each of the five secured debt arrangements under the
Barclays Facility - GBP/EUR:

                                       36


--------------------------------------------------------------------------------


                                                Borrowings       Fully-Extended
              Local Currency                outstanding (in $)    Maturity(1)
GBP                                                   $217,350   December 2023
GBP                                                    156,958   February 2023
GBP                                                    149,830    October 2024
GBP                                                    121,716   September 2023
Sub-total/Weighted-Average                            $645,854   November 2023
EUR                                                    179,586     see below
Total/Weighted-Average                                $825,440


-------
(1) Assumes underlying loans extend to fully extended maturity and extensions at
our option are exercised.
The Barclays Facility - EUR has an "evergreen" feature such that the facility
continues for one year and can be terminated by either party on certain dates
with, depending on the date of notice, a minimum of nine to twelve month notice.
As of March 31, 2020, we had $825.4 million (£520.0 million and €162.8 million
assuming conversion into U.S.
dollars) of borrowings outstanding under the Barclays Facility - GBP/EUR secured
by five of our commercial mortgage loans.
Debt Covenants
The guarantees related to our secured debt arrangements contain the following
financial covenants (i) tangible net worth must be greater than $1.25 billion
plus 75% of the net cash proceeds of any equity issuance after March 31, 2017
(ii) our ratio of total indebtedness to tangible net worth cannot be greater
than 3.75:1; and (iii) our liquidity cannot be less than an amount equal to the
greater of 5% of total recourse indebtedness or $30.0 million.
Senior Secured Term Loan
In May 2019, we entered into the $500.0 million senior secured term loan. During
the three months ended March 31, 2020, we repaid $1.3 million of principal
related to the senior secured term loan. The senior secured term loan bears
interest at LIBOR plus 2.75% and was issued at a price of 99.5%. The outstanding
balance as of March 31, 2020 was $496.3 million. The senior secured term loan
matures in May 2026 and contains restrictions relating to liens, asset sales,
indebtedness, and investments in non-wholly owned entities. The senior secured
term loan includes the following financial covenants: (i) our ratio of total
recourse debt to tangible net worth cannot be greater than 3:1; and (ii) our
ratio of total unencumbered assets to total pari-passu indebtedness must be at
least 1.25:1.
Convertible Senior Notes
In two separate offerings during 2017, we issued an aggregate principal amount
of $345.0 million of 4.75% Convertible Senior Notes due 2022, for which we
received $337.5 million, after deducting the underwriting discount and offering
expenses. At March 31, 2020, the 2022 Notes had a carrying value of $338.4
million and an unamortized discount of $6.6 million.
During the fourth quarter of 2018, we issued $230.0 million of 5.375%
Convertible Senior Notes due 2023, for which we received $223.7 million after
deducting the underwriting discount and offering expenses. At March 31, 2020,
the 2023 Notes had a carrying value of $224.2 million and an unamortized
discount of $5.8 million.
Cash Generated from Equity Offerings
During the second quarter of 2019, we completed a follow-on public offering of
17,250,000 shares of our common stock, including shares issued pursuant to the
underwriters' option to purchase additional shares, at a price of $18.27 per
share. The aggregate net proceeds from the offering were $314.8 million after
deducting offering expenses.
In March 2020, our board of directors approved a stock repurchase program for up
to an aggregate of $150.0 million of our common stock. In March 2020, we
repurchased 300,000 shares of common stock under this plan for $2.4 million.
Other Potential Sources of Financing

                                       37


--------------------------------------------------------------------------------

Our primary sources of cash currently consist of cash available, which was
$582.1 million as of March 31, 2020, principal and interest payments we receive
on our portfolio of assets, and available borrowings under our secured debt
arrangements. We expect our other sources of cash to consist of cash generated
from operations and prepayments of principal received on our portfolio of
assets. Such prepayments are difficult to estimate in advance. Depending on
market conditions, we may utilize additional borrowings as a source of cash,
which may also include additional secured debt arrangements as well as other
borrowings such as credit facilities, or conduct additional public and private
debt and equity offerings. As of March 31, 2020 we also held $1.2 billion of
unencumbered assets, consisting of $0.2 billion of senior mortgages and $1.0
billion of mezzanine loans.
We maintain policies relating to our borrowings and use of leverage. See
"Leverage Policies" below. In the future, we may seek to raise further equity or
debt capital or engage in other forms of borrowings in order to fund future
investments or to refinance expiring indebtedness.
We generally intend to hold our target assets as long-term investments, although
we may sell certain of our investments in order to manage our interest rate risk
and liquidity needs, meet other operating objectives and adapt to market
conditions.
To maintain our qualification as a REIT under the Internal Revenue Code, we must
distribute annually at least 90% of our REIT taxable income, determined without
regard to the deduction for dividends paid and excluding net capital gain. These
distribution requirements limit our ability to retain earnings and replenish or
increase capital for operations.
Leverage Policies
We use leverage for the sole purpose of financing our portfolio and not for the
purpose of speculating on changes in interest rates. In addition to our secured
debt arrangements and senior secured term loan, we access additional sources of
borrowings. Our charter and bylaws do not limit the amount of indebtedness we
can incur; however, we are subject to and carefully monitor the limits placed on
us by our credit providers and those that assign ratings on our Company.

At March 31, 2020, our debt-to-equity ratio was 1.6 and our portfolio was
comprised of $5.4 billion of commercial mortgage loans and $1.0 billion of
subordinate loans and other lending assets. In order to achieve our return on
equity, we generally finance our mortgage loans with 2.0 to 3.0 turns of
leverage and generally do not finance our subordinate loan portfolio given
built-in inherent structural leverage. Consequently, depending on our portfolio
mix, our debt-to-equity ratio may exceed our previously disclosed thresholds.
Investment Guidelines
Our current investment guidelines, approved by our board of directors, are
comprised of the following:
•     no investment will be made that would cause us to fail to qualify as a REIT

for U.S. federal income tax purposes;

• no investment will be made that would cause us to register as an investment

company under the 1940 Act;

• investments will be predominantly in our target assets;




•     no more than 20% of our cash equity (on a consolidated basis) will be
      invested in any single investment at the time of the investment; and

• until appropriate investments can be identified, the Manager may invest the

proceeds of any offering in interest bearing, short-term investments,

including money market accounts and/or funds, that are consistent with our

intention to qualify as a REIT.




The board of directors must approve any change in or waiver to these investment
guidelines.
Contractual Obligations and Commitments
Our contractual obligations including expected interest payments as of March 31,
2020 are summarized as follows ($ in thousands):


                                       38


--------------------------------------------------------------------------------


                                                                                               More
                     Less than 1                              2 to 3          3 to 5          than 5
                      year (1)         1 to 2 years(1)       years (1)       years (1)       years (1)         Total
Secured debt
arrangements(1)(2) $     344,787     $       1,117,097     $   205,964     $ 2,144,893     $         -     $ 3,812,741
Senior secured
term loan(2)              22,316                22,141          21,965          43,451         523,406         633,279
Convertible senior
notes                     28,750                28,750         363,978         237,211               -         658,689
Unfunded loan
commitments (3)(4)       528,627               729,951         289,918     

    17,482          11,793       1,577,771
Total              $     924,480     $       1,897,939     $   881,825     $ 2,443,037     $   535,199     $ 6,682,480


-------

(1) Assumes underlying assets are financed through the fully extended maturity

date of the secured debt arrangement.

(2) Based on the applicable benchmark rates as of March 31, 2020 on the floating

rate debt for interest payments due.

(3) Based on our expected funding schedule, which is based upon the Manager's

estimates based upon the best information available to the Manager at the

time. There is no assurance that the payments will occur in accordance with

these estimates or at all, which could affect our operating results. Refer to

"Note 15- Commitments and Contingencies" for further detail regarding

unfunded loan commitments.

(4) In connection with the sale of three loans, which sale closed subsequent to

March 31, 2020, as discussed in "Note 18 - Subsequent Events," we were

relieved of future funding obligations totaling $172.6 million, which is

excluded from the above table, all of which was expected to be funded within

two years of March 31, 2020.





Loan Commitments. As of March 31, 2020, we had $1.8 billion of unfunded loan
commitments, comprised of $1.8 billion related to our commercial mortgage loan
portfolio, and $40.5 million related to our subordinate loan portfolio.
Management Agreement. On September 23, 2009, we entered into the Management
Agreement with the Manager pursuant to which the Manager is entitled to receive
a management fee and the reimbursement of certain expenses. The table above does
not include amounts due under the Management Agreement as those obligations do
not have fixed and determinable payments. Pursuant to the Management Agreement,
the Manager is entitled to a base management fee calculated and payable
quarterly in arrears in an amount equal to 1.5% of our stockholders' equity (as
defined in the Management Agreement), per annum. The Manager will use the
proceeds from its management fee in part to pay compensation to its officers and
personnel. We do not reimburse the Manager or its affiliates for the salaries
and other compensation of their personnel, except for the allocable share of the
compensation of (1) our Chief Financial Officer based on the percentage of time
spent on our affairs and (2) other corporate finance, tax, accounting, internal
audit, legal, risk management, operations, compliance and other non-investment
professional personnel of the Manager or its affiliates who spend all or a
portion of their time managing our affairs based on the percentage of time
devoted by such personnel to our affairs. We are also required to reimburse the
Manager for operating expenses related to us incurred by the Manager, including
expenses relating to legal, accounting, due diligence and other services.
Expense reimbursements to the Manager are made in cash on a monthly basis
following the end of each month. Our reimbursement obligation is not subject to
any dollar limitation.
The current term of the Management Agreement will expire on September 29, 2020.
Absent certain action by the independent directors of our board of directors, as
described below, the Management Agreement will automatically renew on each
anniversary for a one-year term. The Management Agreement may be terminated upon
expiration of the one-year term only upon the affirmative vote of at least
two-thirds of our independent directors, based upon (1) unsatisfactory
performance by the Manager that is materially detrimental to us or (2) a
determination that the management fee payable to the Manager is not fair,
subject to the Manager's right to prevent such a termination based on unfair
fees by accepting a mutually acceptable reduction of management fees agreed to
by at least two-thirds of our independent directors. The Manager must be
provided with written notice of any such termination at least 180 days prior to
the expiration of the then existing term and will be paid a termination fee
equal to three times the sum of the average annual base management fee during
the 24-month period immediately preceding the date of termination, calculated as
of the end of the most recently completed fiscal quarter prior to the date of
termination. Amounts payable under the Management Agreement are not fixed and
determinable. Following a meeting by our independent directors in February 2020,
which included a discussion of the Manager's performance and the level of the
management fees thereunder, we determined not to terminate the Management
Agreement.
Forward Currency Contracts. We use forward currency contracts to economically
hedge interest and principal payments due under our loans denominated in
currencies other than U.S. dollars. We have entered into a series of forward
contracts to sell an amount of foreign currency (GBP and EUR) for an agreed upon
amount of U.S. dollars at various dates through December 2024. These forward
contracts were executed to economically fix the U.S. dollar amounts of foreign
denominated cash flows expected to be received by us related to foreign
denominated loan investments. Refer to "Note 10- Derivatives, Net" to the
accompanying condensed consolidated financial statements for details regarding
our forward currency contracts.

                                       39


--------------------------------------------------------------------------------

Interest Rate Swap. In connection with the senior secured term loan, we entered
into an interest rate swap to fix LIBOR at 2.12%, effectively fixing our all-in
coupon on the senior secured term loan at 4.87%. Refer to "Note 10- Derivatives,
Net" to the accompanying condensed consolidated financial statements for details
regarding our interest rate swap.
Off-balance Sheet Arrangements
We do not have any relationships with unconsolidated entities or financial
partnerships, such as entities often referred to as structured investment
vehicles, or special purpose or variable interest entities, established to
facilitate off-balance sheet arrangements or other contractually narrow or
limited purposes. Further, we have not guaranteed any obligations of
unconsolidated entities or entered into any commitment to provide additional
funding to any such entities.
Dividends
We intend to continue to make regular quarterly distributions to holders of our
common stock. U.S. federal income tax law generally requires that a REIT
distribute annually at least 90% of our REIT taxable income, without regard to
the deduction for dividends paid and excluding net capital gains, and that we
pay tax at regular corporate rates to the extent that we annually distribute
less than 100% of our net taxable income. We generally intend over time to pay
dividends to our stockholders in an amount equal to our net taxable income, if
and to the extent authorized by our board of directors. Any distributions we
make are at the discretion of our board of directors and depend upon, among
other things, our actual results of operations. These results and our ability to
pay distributions are affected by various factors, including the net interest
and other income from our portfolio, our operating expenses and any other
expenditures. If our cash available for distribution is less than our net
taxable income, we could be required to sell assets or borrow funds to make cash
distributions or we may make a portion of the required distribution in the form
of a taxable stock distribution or distribution of debt securities.
As of March 31, 2020, we had 6,770,393 shares of Series B Preferred Stock
outstanding, which entitles holders to receive dividends that are payable
quarterly in arrears. The Series B Preferred Stock pay cumulative cash
dividends, which are payable quarterly in equal amounts in arrears on the 15th
day of each January, April, July and October: (i) from, and including, the
original date of issuance of the Series B Preferred Stock to, but
excluding, September 20, 2020, at an initial rate of 8.00% per annum of
the $25.00 per share liquidation preference; and (ii) from, and
including, September 20, 2020, at the rate per annum equal to the greater of (a)
8.00% and (b) a floating rate equal to the 3-month LIBOR rate as calculated on
each applicable date of determination plus 6.46% of the $25.00 liquidation
preference. Except under certain limited circumstances, the Series B Preferred
Stock is generally not convertible into or exchangeable for any other property
or any other of our securities at the election of the holders. On or after
September 21, 2020, we may, at our option, redeem the shares at a redemption
price of $25.00, plus any accrued unpaid distribution through the date of the
redemption.
On June 10, 2019, we redeemed all 6,900,000 shares of Series C Preferred Stock
outstanding. Holders of the Series C Preferred Stock received the redemption
price of $25.00 plus accumulated but unpaid dividends to the redemption date of
$0.2223.

Non-GAAP Financial Measures

Operating Earnings
For the three months ended March 31, 2020, our Operating Earnings were $62.7
million, or $0.40 per share as compared to $68.4 million, or $0.50 per share for
the same period in the prior year. Operating Earnings is a non-GAAP financial
measure that we define as net income available to common stockholders, computed
in accordance with GAAP, adjusted for (i) equity-based compensation expense (a
portion of which may become cash-based upon final vesting and settlement of
awards should the holder elect net share settlement to satisfy income tax
withholding), (ii) any unrealized gains or losses or other non-cash items
included in net income available to common stockholders, (iii) unrealized income
from unconsolidated joint ventures, (iv) foreign currency gains (losses), other
than (a) realized gains/(losses) related to interest income, and (b) forward
point gains/(losses) realized on our foreign currency hedges, (v) the non-cash
amortization expense related to the reclassification of a portion of the Notes
to stockholders' equity in accordance with GAAP, and (vi) provision for loan
losses. Beginning with the quarter ended December 31, 2018, we modified our
definition of Operating Earnings to include the impact from forward points on
our foreign currency hedges, which reflect the interest rate differentials
between the applicable base rate for our foreign currency investments and USD
LIBOR. These forward contracts effectively convert the rate exposure to USD
LIBOR, resulting in additional interest income earned in U.S. dollar terms.
These amounts may not be included in GAAP net income in the same period as this

                                       40


--------------------------------------------------------------------------------

adjustment. Generally these amounts would be included in prior period GAAP net
income as unrealized gains on forward currency contracts. Operating Earnings may
also be adjusted to exclude certain other non-cash items, as determined by the
Manager and approved by a majority of our independent directors.
The weighted-average diluted shares outstanding used for Operating Earnings per
weighted-average diluted share has been adjusted from weighted-average diluted
shares under GAAP to exclude shares issued from a potential conversion of the
Notes. Consistent with the treatment of other unrealized adjustments to
Operating Earnings, these potentially issuable shares are excluded until a
conversion occurs, which we believe is a useful presentation for investors. We
believe that excluding shares issued in connection with a potential conversion
of the Notes from our computation of Operating Earnings per weighted-average
diluted share is useful to investors for various reasons, including the
following: (i) conversion of Notes to shares requires both the holder of a Note
to elect to convert the Note and for us to elect to settle the conversion in the
form of shares; (ii) future conversion decisions by Note holders will be based
on our stock price in the future, which is presently not determinable; (iii) the
exclusion of shares issued in connection with a potential conversion of the
Notes from the computation of Operating Earnings per weighted-average diluted
share is consistent with how we treat other unrealized items in our computation
of Operating Earnings per weighted-average diluted share; and (iv) we believe
that when evaluating our operating performance, investors and potential
investors consider our Operating Earnings relative to our actual distributions,
which are based on shares outstanding and not shares that might be issued in the
future. The table below summarizes the reconciliation from weighted-average
diluted shares under GAAP to the weighted-average diluted shares used for
Operating Earnings ($ in thousands, except Price):
                                                     Three months ended March 31,
                                                      2020                    2019
Weighted-Averages                                    Shares                  Shares
Weighted-average diluted shares - GAAP            153,948,191               

134,607,107


Unvested RSUs                                       2,007,242               

1,849,564


Weighted-average diluted shares - Operating
Earnings                                          155,955,433               136,456,671




                              Three months ended March 31, 2020                 Three months ended March 31, 2019

Weighted-Averages              Face            Price        Shares               Face           Price        Shares
Weighted-average
diluted shares - GAAP                                    153,948,191                                      164,683,086
2019 Notes(1)                    N/A               N/A             -      $

    26,487           $17.17    (1,542,708 )
2022 Notes              $    345,000            $19.91             -      $    345,000           $19.91   (17,327,970 )
2023 Notes              $    230,000            $20.53             -      $    230,000           $20.53   (11,205,301 )

Unvested RSUs                    N/A               N/A     2,007,242               N/A              N/A     1,849,564
Weighted-average
diluted shares -
Operating Earnings                                       155,955,433                                      136,456,671


-------

(1) Face represents the weighted-average balances during the period.




                        Computation of Share Count for Operating Earnings
                                                                  Three 

months ended March 31,


                                                                      2020               2019

Basic weighted-average shares of common stock outstanding 153,948,191 134,607,107 Weighted-average unvested RSUs

                                     2,007,242           1,849,564
Weighted-average diluted shares - Operating Earnings             

155,955,433 136,456,671





In order to evaluate the effective yield of the portfolio, we use Operating
Earnings to reflect the net investment income of our portfolio as adjusted to
include the net interest expense related to our derivative instruments.
Operating Earnings allows us to isolate the net interest expense associated with
our swaps in order to monitor and project our full cost of borrowings. We also
believe that our investors use Operating Earnings, or a comparable supplemental
performance

                                       41


--------------------------------------------------------------------------------

measure, to evaluate and compare the performance of our company and our peers
and, as such, we believe that the disclosure of Operating Earnings is useful to
our investors. Forward points effectively convert our foreign rate exposure to
USD LIBOR, which we believe is a better reflection of our operating results and
we believe the inclusion of the resulting gain or loss in Operating Earnings is
useful to our investors. Our operating results are primarily comprised of
earning interest income on our investments net of borrowing and administrative
costs.
A significant limitation associated with Operating Earnings as a measure of our
financial performance over any period is that it excludes unrealized gains
(losses) from investments. In addition, our presentation of Operating Earnings
may not be comparable to similarly-titled measures of other companies, who may
use different calculations. As a result, Operating Earnings should not be
considered as a substitute for our GAAP net income as a measure of our financial
performance or any measure of our liquidity under GAAP.
The table below summarizes the reconciliation from net income (loss) available
to common stockholders to Operating Earnings ($ in thousands):
                                                               Three months 

ended March 31,


                                                                  2020      

2019


Net income (loss) available to common stockholders         $      (131,227 )     $      60,923
Adjustments:
Equity-based compensation expense                                    4,263               3,901
Unrealized loss on interest rate swap                               35,548                   -
(Gain) loss on currency forwards                                   (70,491 )             6,720
Foreign currency (gain) loss, net                                   37,949              (6,894 )
Realized gains relating to interest income on foreign                  256                 418
currency hedges, net
Realized gains relating to forward points on foreign                 2,171               2,431
currency hedges, net
Amortization of the convertible senior notes related to                754                 909
equity reclassification
Provision for loan losses                                          183,465                   -
Total adjustments:                                                 193,915               7,485
Operating Earnings                                         $        62,688       $      68,408
Diluted Operating Earnings per share of common stock (1)   $          0.40       $        0.50
Basic weighted-average shares of common stock outstanding      153,948,191  

134,607,107


Weighted-average diluted shares - Operating Earnings           155,955,433  

136,456,671

-------


(1) For the computation of diluted Operating Earnings per share of common stock,
for the three months ended March 31, 2020 and 2019, $0.0 million and $8.4
million, respectively, of interest expense related to the Notes is not deducted
from the numerator and the potentially dilutive shares related to the Notes are
excluded from the denominator.

Book Value Per Share



The table below calculates our book value per share ($ in thousands, except per
share data):

                                            March 31, 2020           December 31, 2019
Stockholders' Equity                    $           2,400,911     $           2,629,975
   Series B Preferred Stock
(Liquidation Preference)                             (169,260 )                (169,260 )
Common Stockholders' Equity             $           2,231,651     $           2,460,715
Common Stock                                      153,740,547               153,537,296
Book value per share                    $               14.52     $               16.03


The table below shows the changes in our book value per share:


                                           Book value per share
Book value per share at December 31, 2019 $                16.03
Net unrealized gain on currency hedges                      0.20



                                       42


--------------------------------------------------------------------------------

Repurchase of common stock                                                

0.01


Decrease in fair value on interest rate swap                             (0.24 )
Vesting and delivery of RSUs                                             (0.07 )
Other                                                                    (0.01 )
Book value per share at March 31, 2020 prior to CECL Allowances        $ 15.92
Specific CECL Allowance                                                $ (0.98 )
Book value per share at March 31, 2020 prior to General CECL Allowance $ 14.94
General CECL Allowance                                                 $ (0.42 )
Book value per share at March 31, 2020                                 $ 

14.52





We believe that presenting book value per share with sub-totals prior to the
CECL Allowances is useful for investors for various reasons. These include,
among other things, the calculations for our covenants related to tangible net
worth and debt-to-equity under our secured debt arrangements and senior secured
term loan B permit us to add the General CECL Allowance to our GAAP
stockholders' equity.

                                       43

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses